Preventing potential drug interactions in community pharmacy.

Preventing potential drug interactions in community pharmacy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Preventing potential drug interactions in community pharmacy. Abstract Text:

With ongoing debate on health care reform including improved pharmaceutical care, there is much current concern about drug interactions and their prevention. Many patients visit more than one doctor for their different diseases and receive more than one drug at a time, and often doctors are unaware of all the medications their patients are taking and the risks to which their patients are exposed when treated with multiple drugs. Pharmacists in the community setting or hospital are the most accessible health care providers able to intervene when faced with potential drug interactions that may occur during patients' multiple drug therapy. A few selected examples of potential drug-drug interactions and interventions instituted are presented in this paper. Possible mechanisms for the drug interactions are also discussed. It is hoped that more documentation of pharmacists' involvement in such interventions will demonstrate the true value of pharmaceutical care.

Preventing potential drug interactions in community pharmacy. Publishing Authors By Initials

For similar biochemical phenomena, metabolism, and nutrition: metabolism: pharmacokinetics research abstracts see: biochemical phenomena, metabolism, and nutrition: metabolism: pharmacokinetics research

PUBMED ID PMID:

MEDLINE DATE:

Preventing potential drug interactions in community pharmacy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of clinical pharmacy and therapeutics

VOLUME: 19

Page Numbers: 371-9

Journal Abbreviation: J Clin Pharm Ther

ISSN: 0269-4727

DAY: 28

MONTH: Dec

YEAR: 1994

Preventing potential drug interactions in community pharmacy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8704308

Preventing potential drug interactions in community pharmacy. Keywords Mesh Terms:

KEYWORDS: Pharmacokinetics

MESH TERMS: adverse effects

Chemical & Substance for Abstract: Preventing potential drug interactions in community pharmacy. Information

Substance Name: Ciprofloxacin

Registry Number: 85721-33-1

Grant and Affiliation Information for Preventing potential drug interactions in community pharmacy.

AFFILIATION: Department of Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles 90033.

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Clin Pharm Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Preventing potential drug interactions in community pharmacy Related Publications

• Analysis of the quantitative structure activity relationship of technetium-99m-labeled diaminedithiol (DADT) and propylene-amine-oxime (PAO) brain blood flow analogues.
• Assessment of space radiation effects on solid-state Brillouin phase conjugate mirrors.
• Caco-2 cell permeability vs human gastrointestinal absorption: QSPR analysis.
• Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relationship (SSAR) analysis.
• Chimeric RNA/DNA oligonucleotide-based gene therapy.
• Construction of a dense SNP map for bovine chromosome 6 to assist the assembly of the bovine genome sequence.
• Design and discovery of new drugs by stepping-up and stepping-down approaches.
• Development of HIV protease inhibitors: a survey.
• Development of HIV protease inhibitors: a survey.
• Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
• Effects of furosemide on renal calcium handling.
• Fungal metabolites and Chinese herbal medicine as immunostimulants.
• Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey.
• Immunopharmacological and biochemical bases of Chinese herbal medicine.
• In search of ideal antihypertensive drugs: progress in five decades.
• Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging.
• Intrapleural streptokinase for the treatment of childhood empyema.
• MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4).
• MOSQUITOES OF TAIWAN: GENUS TOXORHYNCHITES THEOBALD.
• Natural products and their derivatives as cancer chemopreventive agents.
• Outcome of large hemispheric infarcts: an experience of 50 patients in Taiwan.
• Phenotypic Characteristics of Bone in Carbonic Anhydrase II-Deficient Mice.
• Prochlorperazine and chlorpromazine: a comparative clinical trial.
• Purine analogs as CDK enzyme inhibitory agents: a survey and QSAR analysis.
• Regional versus general anesthesia for hip surgery in older patients: does the choice affect patient outcome?
• Ribonucleotide reductase inhibitors as anticancer and antiviral agents.
• Structures, properties and disposition of drugs.
• Unexpected Severe LVH in the Elderly: Consider Fabry's Disease.
• [CARDIOVASCULAR DISEASES IN TAIWAN.]
• [CARDIOVASCULAR DISEASES IN TAIWAN.]